In Q1 FY2026 (ended March 31, 2026), Lumexa Imaging reported revenue of $252.5 million, up 3.1% year-over-year. Net income surged 122.3% to $1.7 million, while operating income fell 24.0% to $19.4 million. Diluted EPS was $0.02, up 118.2% from the prior year. The company held $51.2 million in cash, $599.6 million in equity, and $832.1 million in long-term debt.
•Revenue increased 3.1% YoY to $252.5 million.
•Net income rose 122.3% to $1.7 million; diluted EPS of $0.02.
•Operating income declined 24.0% to $19.4 million.
•Long-term debt of $832.1 million vs. cash of $51.2 million.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services X-ray, ultrasound, and mammography diagnostic and screening imaging services. Founded in 2018, Lumexa Imaging is based in Raleigh, North Carolina.
What does Lumexa Imaging Holdings, Inc. (LMRI) do?
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centers in the United States. The company provides a comprehensive range of outpatient medical imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. These services help physicians diagnose and monitor various medical conditions without the need for hospital admission. By focusing on outpatient care, Lumexa aims to offer convenient and accessible imaging solutions to patients across its network of centers.
Where is Lumexa Imaging Holdings (LMRI) listed and in what currency?
Lumexa Imaging Holdings, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol LMRI. The company's shares are traded in US Dollars (USD), reflecting its primary operations and reporting in the United States. As a Nasdaq-listed company, Lumexa is subject to the exchange's listing standards and regulatory requirements, providing investors with transparency and liquidity in the US equity market.
What sector and industry does Lumexa Imaging (LMRI) operate in?
Lumexa Imaging Holdings, Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. While the company itself is a provider of diagnostic imaging services rather than a manufacturer of medical devices, its industry classification reflects its close association with medical imaging technology and equipment used in diagnostics. The Medical Devices industry encompasses a wide range of products and services that support patient diagnosis and treatment, and Lumexa's imaging centers utilize advanced devices such as MRI, CT, and PET scanners to deliver essential healthcare services.
Where is Lumexa Imaging Holdings headquartered and what markets does it serve?
Lumexa Imaging Holdings, Inc. is headquartered in Raleigh, North Carolina, United States. The company operates diagnostic imaging centers across the United States, serving local communities with outpatient medical imaging services. By focusing on the US market, Lumexa caters to a diverse patient population requiring diagnostic imaging for various health conditions. Its centers are strategically located to provide accessible care, and the company's services are utilized by physicians and healthcare providers to aid in diagnosis and treatment planning.
How does Lumexa Imaging (LMRI) generate revenue?
Lumexa Imaging Holdings, Inc. generates revenue by operating diagnostic imaging centers that provide outpatient medical imaging services. Patients or their insurance providers pay for procedures such as MRI, CT, PET scans, X-ray, ultrasound, and mammography. The company earns fees for each imaging study performed, which are typically billed to health insurance companies, government programs like Medicare and Medicaid, or directly to patients. By maintaining a network of imaging centers, Lumexa can serve a steady stream of patients referred by physicians, generating recurring revenue from diagnostic services.